
Franklin Resources’s Spyre Therapeutics SYRE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.9M | Buy |
795,275
+34,647
| +5% | +$519K | ﹤0.01% | 1073 |
|
2025
Q1 | $12.3M | Sell |
760,628
-14
| -0% | -$226 | ﹤0.01% | 1043 |
|
2024
Q4 | $17.7M | Sell |
760,642
-24
| -0% | -$559 | ﹤0.01% | 946 |
|
2024
Q3 | $23.3M | Buy |
760,666
+18,762
| +3% | +$575K | 0.01% | 851 |
|
2024
Q2 | $17.4M | Hold |
741,904
| – | – | 0.01% | 900 |
|
2024
Q1 | $28.1M | Buy |
741,904
+54,814
| +8% | +$2.08M | 0.01% | 754 |
|
2023
Q4 | $14.8M | Buy |
+687,090
| New | +$14.8M | 0.01% | 833 |
|
2023
Q3 | – | Sell |
-31,364
| Closed | -$14.1K | – | 2769 |
|
2023
Q2 | $14.1K | Hold |
31,364
| – | – | ﹤0.01% | 2673 |
|
2023
Q1 | $9.1K | Hold |
31,364
| – | – | ﹤0.01% | 2282 |
|
2022
Q4 | $14.1K | Hold |
31,364
| – | – | ﹤0.01% | 2289 |
|
2022
Q3 | $16K | Hold |
31,364
| – | – | ﹤0.01% | 2265 |
|
2022
Q2 | $16K | Sell |
31,364
-14,936
| -32% | -$7.62K | ﹤0.01% | 2323 |
|
2022
Q1 | $106K | Buy |
+46,300
| New | +$106K | ﹤0.01% | 2286 |
|